mepron

Generic: atovaquone

Labeler: glaxosmithkline llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name mepron
Generic Name atovaquone
Labeler glaxosmithkline llc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

atovaquone 750 mg/5mL

Manufacturer
GlaxoSmithKline LLC

Identifiers & Regulatory

Product NDC 0173-0547
Product ID 0173-0547_88051971-96da-4b1c-9e64-4a4b9c92f2bd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020500
Listing Expiration 2026-12-31
Marketing Start 1998-09-18

Pharmacologic Class

Established (EPC)
antimalarial [epc] antiprotozoal [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01730547
Hyphenated Format 0173-0547

Supplemental Identifiers

RxCUI
211947 308429
UNII
Y883P1Z2LT
NUI
N0000175482 N0000175485

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mepron (source: ndc)
Generic Name atovaquone (source: ndc)
Application Number NDA020500 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 750 mg/5mL
source: ndc
Packaging
  • 42 POUCH in 1 DOSE PACK (0173-0547-00) / 5 mL in 1 POUCH
source: ndc

Packages (1)

Ingredients (1)

atovaquone (750 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "88051971-96da-4b1c-9e64-4a4b9c92f2bd", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["211947", "308429"], "spl_set_id": ["b426b6bf-f07e-4580-97ae-dfca1ddf5b8f"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "42 POUCH in 1 DOSE PACK (0173-0547-00)  / 5 mL in 1 POUCH", "package_ndc": "0173-0547-00", "marketing_start_date": "19980918"}], "brand_name": "MEPRON", "product_id": "0173-0547_88051971-96da-4b1c-9e64-4a4b9c92f2bd", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "0173-0547", "generic_name": "atovaquone", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MEPRON", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "NDA020500", "marketing_category": "NDA", "marketing_start_date": "19980918", "listing_expiration_date": "20261231"}